Page last updated: 2024-08-17

medroxyprogesterone acetate and Carcinoma, Non-Small Cell Lung

medroxyprogesterone acetate has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aaronson, NK; Blijham, GH; Cobben, EG; Demedts, M; Drenth, BM; Erdkamp, FL; Hillen, HF; Muller, MJ; Schoon, EJ; Schouten, HC; Simons, JP; Smeets, JB; ten Velde, GP; Vansteenkiste, JF; Wouters, EF1

Trials

1 trial(s) available for medroxyprogesterone acetate and Carcinoma, Non-Small Cell Lung

ArticleYear
Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:4

    Topics: Analysis of Variance; Appetite; Body Weight; Carcinoma, Non-Small-Cell Lung; Digestive System Neoplasms; Double-Blind Method; Female; Humans; Lung Neoplasms; Male; Medroxyprogesterone Acetate; Neoplasm Staging; Neoplasms; Progesterone Congeners; Quality of Life; Treatment Outcome

1996